SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), has appointed biotech and finance industry veteran Ron Renaud as a director and non-executive chair of the board of directors.
“We are honored to have Ron Renaud lead our board of directors as we advance our pipeline programs across various stages of development and deliver on key corporate milestones,” said Pascal Touchon, president and chief executive officer of Atara Biotherapeutics. “The board and I are enthusiastic about Ron’s extensive experience, from both the Wall Street and corporate side, in strategic and corporate development, partnering, financing, board and executive leadership, as well as his strong industry relationships.”
“I am very impressed with Atara’s pipeline, technologies and manufacturing platform, and by the quality of the leadership team,” said Ron Renaud. “It is an honor to join such an experienced board and I look forward to helping Atara create significant value for patients and our stockholders.”